nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—ocular cancer—melanoma	0.217	0.359	CtDrD
Dactinomycin—skin cancer—melanoma	0.115	0.191	CtDrD
Dactinomycin—germ cell cancer—melanoma	0.0967	0.16	CtDrD
Dactinomycin—ABCB1—melanoma	0.0956	1	CbGaD
Dactinomycin—ABCC1—Vemurafenib—melanoma	0.0928	0.43	CbGbCtD
Dactinomycin—kidney cancer—melanoma	0.09	0.149	CtDrD
Dactinomycin—sarcoma—melanoma	0.0858	0.142	CtDrD
Dactinomycin—ABCG2—Vemurafenib—melanoma	0.0621	0.288	CbGbCtD
Dactinomycin—ABCC1—Docetaxel—melanoma	0.0318	0.148	CbGbCtD
Dactinomycin—ABCG2—Docetaxel—melanoma	0.0213	0.0988	CbGbCtD
Dactinomycin—ABCB1—Docetaxel—melanoma	0.00768	0.0356	CbGbCtD
Dactinomycin—ABCC6—dermis—melanoma	0.00571	0.535	CbGeAlD
Dactinomycin—Radiation injury—Temozolomide—melanoma	0.00393	0.0695	CcSEcCtD
Dactinomycin—Venoocclusive disease—Carmustine—melanoma	0.0037	0.0655	CcSEcCtD
Dactinomycin—Radiation recall reaction (dermatologic)—Docetaxel—melanoma	0.00167	0.0295	CcSEcCtD
Dactinomycin—Recall phenomenon—Docetaxel—melanoma	0.00158	0.028	CcSEcCtD
Dactinomycin—Neutropenic sepsis—Docetaxel—melanoma	0.00158	0.028	CcSEcCtD
Dactinomycin—Folliculitis—Vemurafenib—melanoma	0.00128	0.0227	CcSEcCtD
Dactinomycin—Hepatotoxicity—Vemurafenib—melanoma	0.00105	0.0185	CcSEcCtD
Dactinomycin—Myelosuppression—Bleomycin—melanoma	0.00104	0.0184	CcSEcCtD
Dactinomycin—Myelosuppression—Carmustine—melanoma	0.00091	0.0161	CcSEcCtD
Dactinomycin—Myelosuppression—Temozolomide—melanoma	0.00088	0.0155	CcSEcCtD
Dactinomycin—ABCC6—eye—melanoma	0.000855	0.0802	CbGeAlD
Dactinomycin—ABCC6—retina—melanoma	0.000848	0.0795	CbGeAlD
Dactinomycin—Multi-organ failure—Docetaxel—melanoma	0.000842	0.0149	CcSEcCtD
Dactinomycin—Febrile neutropenia—Bleomycin—melanoma	0.000813	0.0144	CcSEcCtD
Dactinomycin—Febrile neutropenia—Carmustine—melanoma	0.000709	0.0125	CcSEcCtD
Dactinomycin—ABCC1—hair follicle—melanoma	0.000688	0.0645	CbGeAlD
Dactinomycin—Febrile neutropenia—Temozolomide—melanoma	0.000686	0.0121	CcSEcCtD
Dactinomycin—Ascites—Docetaxel—melanoma	0.000604	0.0107	CcSEcCtD
Dactinomycin—Raised liver function tests—Docetaxel—melanoma	0.000594	0.0105	CcSEcCtD
Dactinomycin—Myelosuppression—Docetaxel—melanoma	0.000585	0.0103	CcSEcCtD
Dactinomycin—Extravasation—Bleomycin—melanoma	0.00056	0.00991	CcSEcCtD
Dactinomycin—Hepatotoxicity—Carmustine—melanoma	0.000553	0.00977	CcSEcCtD
Dactinomycin—Necrosis—Carmustine—melanoma	0.000544	0.00961	CcSEcCtD
Dactinomycin—Hepatotoxicity—Temozolomide—melanoma	0.000534	0.00944	CcSEcCtD
Dactinomycin—Coagulopathy—Temozolomide—melanoma	0.00053	0.00937	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.000527	0.00933	CcSEcCtD
Dactinomycin—Ulcer—Bleomycin—melanoma	0.000517	0.00914	CcSEcCtD
Dactinomycin—Extravasation—Carmustine—melanoma	0.000489	0.00865	CcSEcCtD
Dactinomycin—ABCC6—head—melanoma	0.000485	0.0455	CbGeAlD
Dactinomycin—Febrile neutropenia—Docetaxel—melanoma	0.000456	0.00806	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.000448	0.00791	CcSEcCtD
Dactinomycin—Eruption—Docetaxel—melanoma	0.000446	0.00788	CcSEcCtD
Dactinomycin—Phlebitis—Bleomycin—melanoma	0.000412	0.00728	CcSEcCtD
Dactinomycin—Aplastic anaemia—Temozolomide—melanoma	0.000387	0.00685	CcSEcCtD
Dactinomycin—Erythema multiforme—Vemurafenib—melanoma	0.000383	0.00677	CcSEcCtD
Dactinomycin—Sepsis—Carmustine—melanoma	0.00037	0.00655	CcSEcCtD
Dactinomycin—Chills—Vemurafenib—melanoma	0.000364	0.00643	CcSEcCtD
Dactinomycin—Phlebitis—Carmustine—melanoma	0.00036	0.00636	CcSEcCtD
Dactinomycin—Alopecia—Vemurafenib—melanoma	0.000358	0.00633	CcSEcCtD
Dactinomycin—Hepatotoxicity—Docetaxel—melanoma	0.000355	0.00628	CcSEcCtD
Dactinomycin—Erythema—Vemurafenib—melanoma	0.000353	0.00624	CcSEcCtD
Dactinomycin—Necrosis—Docetaxel—melanoma	0.000349	0.00618	CcSEcCtD
Dactinomycin—Hepatic failure—Temozolomide—melanoma	0.000333	0.00589	CcSEcCtD
Dactinomycin—Extravasation—Docetaxel—melanoma	0.000314	0.00556	CcSEcCtD
Dactinomycin—Myalgia—Vemurafenib—melanoma	0.0003	0.00531	CcSEcCtD
Dactinomycin—SLC22A5—retina—melanoma	0.000299	0.0281	CbGeAlD
Dactinomycin—Pancytopenia—Bleomycin—melanoma	0.000291	0.00515	CcSEcCtD
Dactinomycin—Infection—Vemurafenib—melanoma	0.000286	0.00506	CcSEcCtD
Dactinomycin—Liver function test abnormal—Carmustine—melanoma	0.000286	0.00506	CcSEcCtD
Dactinomycin—Pneumonia—Bleomycin—melanoma	0.000275	0.00486	CcSEcCtD
Dactinomycin—ABCC1—mammalian vulva—melanoma	0.000273	0.0256	CbGeAlD
Dactinomycin—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00027	0.00477	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00027	0.00477	CcSEcCtD
Dactinomycin—Dysphagia—Carmustine—melanoma	0.000268	0.00473	CcSEcCtD
Dactinomycin—Stomatitis—Bleomycin—melanoma	0.000267	0.00471	CcSEcCtD
Dactinomycin—ABCB1—blood vessel—melanoma	0.000264	0.0247	CbGeAlD
Dactinomycin—SLC22A5—skin of body—melanoma	0.000263	0.0246	CbGeAlD
Dactinomycin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000262	0.00464	CcSEcCtD
Dactinomycin—Dysphagia—Temozolomide—melanoma	0.000259	0.00457	CcSEcCtD
Dactinomycin—Pancytopenia—Carmustine—melanoma	0.000254	0.0045	CcSEcCtD
Dactinomycin—Oesophagitis—Docetaxel—melanoma	0.000251	0.00443	CcSEcCtD
Dactinomycin—Neutropenia—Carmustine—melanoma	0.00025	0.00443	CcSEcCtD
Dactinomycin—Decreased appetite—Vemurafenib—melanoma	0.00025	0.00442	CcSEcCtD
Dactinomycin—Fatigue—Vemurafenib—melanoma	0.000248	0.00439	CcSEcCtD
Dactinomycin—Pancytopenia—Temozolomide—melanoma	0.000246	0.00434	CcSEcCtD
Dactinomycin—Neutropenia—Temozolomide—melanoma	0.000242	0.00428	CcSEcCtD
Dactinomycin—Pneumonia—Carmustine—melanoma	0.00024	0.00425	CcSEcCtD
Dactinomycin—Sepsis—Docetaxel—melanoma	0.000238	0.00421	CcSEcCtD
Dactinomycin—Stomatitis—Carmustine—melanoma	0.000233	0.00411	CcSEcCtD
Dactinomycin—Pneumonia—Temozolomide—melanoma	0.000232	0.0041	CcSEcCtD
Dactinomycin—Phlebitis—Docetaxel—melanoma	0.000231	0.00409	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000229	0.00404	CcSEcCtD
Dactinomycin—Flushing—Bleomycin—melanoma	0.000228	0.00403	CcSEcCtD
Dactinomycin—Body temperature increased—Vemurafenib—melanoma	0.000228	0.00402	CcSEcCtD
Dactinomycin—ABCG2—mammalian vulva—melanoma	0.000226	0.0212	CbGeAlD
Dactinomycin—Stomatitis—Temozolomide—melanoma	0.000225	0.00398	CcSEcCtD
Dactinomycin—Hepatic failure—Docetaxel—melanoma	0.000222	0.00392	CcSEcCtD
Dactinomycin—Chills—Bleomycin—melanoma	0.00022	0.00389	CcSEcCtD
Dactinomycin—Alopecia—Bleomycin—melanoma	0.000217	0.00384	CcSEcCtD
Dactinomycin—Erythema—Bleomycin—melanoma	0.000214	0.00378	CcSEcCtD
Dactinomycin—Hypersensitivity—Vemurafenib—melanoma	0.000212	0.00375	CcSEcCtD
Dactinomycin—Hepatitis—Temozolomide—melanoma	0.000207	0.00366	CcSEcCtD
Dactinomycin—Asthenia—Vemurafenib—melanoma	0.000207	0.00365	CcSEcCtD
Dactinomycin—Pharyngitis—Temozolomide—melanoma	0.000206	0.00363	CcSEcCtD
Dactinomycin—Lethargy—Docetaxel—melanoma	0.000203	0.00359	CcSEcCtD
Dactinomycin—Flushing—Carmustine—melanoma	0.000199	0.00352	CcSEcCtD
Dactinomycin—Ill-defined disorder—Bleomycin—melanoma	0.000198	0.00351	CcSEcCtD
Dactinomycin—Anaemia—Bleomycin—melanoma	0.000198	0.00349	CcSEcCtD
Dactinomycin—Diarrhoea—Vemurafenib—melanoma	0.000197	0.00348	CcSEcCtD
Dactinomycin—Erythema multiforme—Temozolomide—melanoma	0.000196	0.00346	CcSEcCtD
Dactinomycin—Malaise—Bleomycin—melanoma	0.000193	0.00341	CcSEcCtD
Dactinomycin—Flushing—Temozolomide—melanoma	0.000192	0.0034	CcSEcCtD
Dactinomycin—Leukopenia—Bleomycin—melanoma	0.000191	0.00338	CcSEcCtD
Dactinomycin—Alopecia—Carmustine—melanoma	0.000189	0.00335	CcSEcCtD
Dactinomycin—Erythema—Carmustine—melanoma	0.000187	0.0033	CcSEcCtD
Dactinomycin—Chills—Temozolomide—melanoma	0.000186	0.00329	CcSEcCtD
Dactinomycin—Liver function test abnormal—Docetaxel—melanoma	0.000184	0.00325	CcSEcCtD
Dactinomycin—Vomiting—Vemurafenib—melanoma	0.000183	0.00324	CcSEcCtD
Dactinomycin—Alopecia—Temozolomide—melanoma	0.000183	0.00324	CcSEcCtD
Dactinomycin—Myalgia—Bleomycin—melanoma	0.000182	0.00322	CcSEcCtD
Dactinomycin—Rash—Vemurafenib—melanoma	0.000182	0.00321	CcSEcCtD
Dactinomycin—Erythema—Temozolomide—melanoma	0.00018	0.00319	CcSEcCtD
Dactinomycin—Discomfort—Bleomycin—melanoma	0.00018	0.00318	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000179	0.00317	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000179	0.00317	CcSEcCtD
Dactinomycin—Oedema—Bleomycin—melanoma	0.000174	0.00308	CcSEcCtD
Dactinomycin—Infection—Bleomycin—melanoma	0.000173	0.00306	CcSEcCtD
Dactinomycin—Anaemia—Carmustine—melanoma	0.000172	0.00305	CcSEcCtD
Dactinomycin—Dysphagia—Docetaxel—melanoma	0.000172	0.00304	CcSEcCtD
Dactinomycin—Nausea—Vemurafenib—melanoma	0.000171	0.00302	CcSEcCtD
Dactinomycin—Thrombocytopenia—Bleomycin—melanoma	0.000171	0.00302	CcSEcCtD
Dactinomycin—Ill-defined disorder—Temozolomide—melanoma	0.000167	0.00296	CcSEcCtD
Dactinomycin—Leukopenia—Carmustine—melanoma	0.000167	0.00295	CcSEcCtD
Dactinomycin—Anaemia—Temozolomide—melanoma	0.000167	0.00295	CcSEcCtD
Dactinomycin—Anorexia—Bleomycin—melanoma	0.000166	0.00294	CcSEcCtD
Dactinomycin—Pancytopenia—Docetaxel—melanoma	0.000163	0.00289	CcSEcCtD
Dactinomycin—Malaise—Temozolomide—melanoma	0.000163	0.00287	CcSEcCtD
Dactinomycin—Leukopenia—Temozolomide—melanoma	0.000161	0.00285	CcSEcCtD
Dactinomycin—Neutropenia—Docetaxel—melanoma	0.000161	0.00284	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000159	0.00281	CcSEcCtD
Dactinomycin—Myalgia—Carmustine—melanoma	0.000159	0.00281	CcSEcCtD
Dactinomycin—Pneumonia—Docetaxel—melanoma	0.000154	0.00273	CcSEcCtD
Dactinomycin—Myalgia—Temozolomide—melanoma	0.000153	0.00271	CcSEcCtD
Dactinomycin—Oedema—Carmustine—melanoma	0.000152	0.00269	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000152	0.00269	CcSEcCtD
Dactinomycin—Discomfort—Temozolomide—melanoma	0.000152	0.00268	CcSEcCtD
Dactinomycin—Decreased appetite—Bleomycin—melanoma	0.000152	0.00268	CcSEcCtD
Dactinomycin—Infection—Carmustine—melanoma	0.000151	0.00267	CcSEcCtD
Dactinomycin—Stomatitis—Docetaxel—melanoma	0.00015	0.00264	CcSEcCtD
Dactinomycin—Pain—Bleomycin—melanoma	0.000149	0.00264	CcSEcCtD
Dactinomycin—Thrombocytopenia—Carmustine—melanoma	0.000149	0.00264	CcSEcCtD
Dactinomycin—Oedema—Temozolomide—melanoma	0.000147	0.0026	CcSEcCtD
Dactinomycin—Infection—Temozolomide—melanoma	0.000146	0.00258	CcSEcCtD
Dactinomycin—Anorexia—Carmustine—melanoma	0.000145	0.00257	CcSEcCtD
Dactinomycin—Thrombocytopenia—Temozolomide—melanoma	0.000144	0.00255	CcSEcCtD
Dactinomycin—Feeling abnormal—Bleomycin—melanoma	0.000144	0.00254	CcSEcCtD
Dactinomycin—Agranulocytosis—Docetaxel—melanoma	0.000143	0.00253	CcSEcCtD
Dactinomycin—Anorexia—Temozolomide—melanoma	0.00014	0.00248	CcSEcCtD
Dactinomycin—ABCB1—retina—melanoma	0.000139	0.013	CbGeAlD
Dactinomycin—Musculoskeletal discomfort—Carmustine—melanoma	0.000139	0.00245	CcSEcCtD
Dactinomycin—Body temperature increased—Bleomycin—melanoma	0.000138	0.00244	CcSEcCtD
Dactinomycin—Hepatitis—Docetaxel—melanoma	0.000138	0.00243	CcSEcCtD
Dactinomycin—Pharyngitis—Docetaxel—melanoma	0.000137	0.00242	CcSEcCtD
Dactinomycin—ABCC1—lymph node—melanoma	0.000137	0.0128	CbGeAlD
Dactinomycin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000134	0.00237	CcSEcCtD
Dactinomycin—Decreased appetite—Carmustine—melanoma	0.000132	0.00234	CcSEcCtD
Dactinomycin—Erythema multiforme—Docetaxel—melanoma	0.00013	0.0023	CcSEcCtD
Dactinomycin—Pain—Carmustine—melanoma	0.00013	0.0023	CcSEcCtD
Dactinomycin—Hypersensitivity—Bleomycin—melanoma	0.000129	0.00227	CcSEcCtD
Dactinomycin—Decreased appetite—Temozolomide—melanoma	0.000128	0.00226	CcSEcCtD
Dactinomycin—Flushing—Docetaxel—melanoma	0.000128	0.00226	CcSEcCtD
Dactinomycin—Fatigue—Temozolomide—melanoma	0.000127	0.00224	CcSEcCtD
Dactinomycin—Pain—Temozolomide—melanoma	0.000126	0.00222	CcSEcCtD
Dactinomycin—Feeling abnormal—Carmustine—melanoma	0.000125	0.00222	CcSEcCtD
Dactinomycin—Asthenia—Bleomycin—melanoma	0.000125	0.00221	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Carmustine—melanoma	0.000125	0.0022	CcSEcCtD
Dactinomycin—Chills—Docetaxel—melanoma	0.000124	0.00218	CcSEcCtD
Dactinomycin—Alopecia—Docetaxel—melanoma	0.000122	0.00215	CcSEcCtD
Dactinomycin—Feeling abnormal—Temozolomide—melanoma	0.000121	0.00214	CcSEcCtD
Dactinomycin—Abdominal pain—Carmustine—melanoma	0.00012	0.00213	CcSEcCtD
Dactinomycin—Body temperature increased—Carmustine—melanoma	0.00012	0.00213	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Temozolomide—melanoma	0.00012	0.00213	CcSEcCtD
Dactinomycin—SLC22A5—lymph node—melanoma	0.00012	0.0113	CbGeAlD
Dactinomycin—Erythema—Docetaxel—melanoma	0.00012	0.00212	CcSEcCtD
Dactinomycin—Abdominal pain—Temozolomide—melanoma	0.000116	0.00206	CcSEcCtD
Dactinomycin—Body temperature increased—Temozolomide—melanoma	0.000116	0.00206	CcSEcCtD
Dactinomycin—ABCG2—lymph node—melanoma	0.000113	0.0106	CbGeAlD
Dactinomycin—Hypersensitivity—Carmustine—melanoma	0.000112	0.00198	CcSEcCtD
Dactinomycin—ABCB1—mammalian vulva—melanoma	0.000111	0.0104	CbGeAlD
Dactinomycin—Vomiting—Bleomycin—melanoma	0.000111	0.00196	CcSEcCtD
Dactinomycin—Anaemia—Docetaxel—melanoma	0.000111	0.00196	CcSEcCtD
Dactinomycin—Rash—Bleomycin—melanoma	0.00011	0.00194	CcSEcCtD
Dactinomycin—Asthenia—Carmustine—melanoma	0.000109	0.00193	CcSEcCtD
Dactinomycin—Hypersensitivity—Temozolomide—melanoma	0.000108	0.00192	CcSEcCtD
Dactinomycin—Leukopenia—Docetaxel—melanoma	0.000107	0.0019	CcSEcCtD
Dactinomycin—Asthenia—Temozolomide—melanoma	0.000106	0.00187	CcSEcCtD
Dactinomycin—Diarrhoea—Carmustine—melanoma	0.000104	0.00184	CcSEcCtD
Dactinomycin—Nausea—Bleomycin—melanoma	0.000104	0.00183	CcSEcCtD
Dactinomycin—Myalgia—Docetaxel—melanoma	0.000102	0.0018	CcSEcCtD
Dactinomycin—Diarrhoea—Temozolomide—melanoma	0.000101	0.00178	CcSEcCtD
Dactinomycin—Oedema—Docetaxel—melanoma	9.79e-05	0.00173	CcSEcCtD
Dactinomycin—Infection—Docetaxel—melanoma	9.72e-05	0.00172	CcSEcCtD
Dactinomycin—Vomiting—Carmustine—melanoma	9.68e-05	0.00171	CcSEcCtD
Dactinomycin—Rash—Carmustine—melanoma	9.6e-05	0.0017	CcSEcCtD
Dactinomycin—Thrombocytopenia—Docetaxel—melanoma	9.58e-05	0.00169	CcSEcCtD
Dactinomycin—Vomiting—Temozolomide—melanoma	9.36e-05	0.00165	CcSEcCtD
Dactinomycin—Anorexia—Docetaxel—melanoma	9.33e-05	0.00165	CcSEcCtD
Dactinomycin—Rash—Temozolomide—melanoma	9.28e-05	0.00164	CcSEcCtD
Dactinomycin—Nausea—Carmustine—melanoma	9.04e-05	0.0016	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Docetaxel—melanoma	8.92e-05	0.00158	CcSEcCtD
Dactinomycin—Nausea—Temozolomide—melanoma	8.74e-05	0.00155	CcSEcCtD
Dactinomycin—Decreased appetite—Docetaxel—melanoma	8.51e-05	0.0015	CcSEcCtD
Dactinomycin—Fatigue—Docetaxel—melanoma	8.44e-05	0.00149	CcSEcCtD
Dactinomycin—Pain—Docetaxel—melanoma	8.37e-05	0.00148	CcSEcCtD
Dactinomycin—Feeling abnormal—Docetaxel—melanoma	8.06e-05	0.00143	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Docetaxel—melanoma	8e-05	0.00141	CcSEcCtD
Dactinomycin—ABCB1—head—melanoma	7.96e-05	0.00746	CbGeAlD
Dactinomycin—Abdominal pain—Docetaxel—melanoma	7.74e-05	0.00137	CcSEcCtD
Dactinomycin—Body temperature increased—Docetaxel—melanoma	7.74e-05	0.00137	CcSEcCtD
Dactinomycin—Hypersensitivity—Docetaxel—melanoma	7.21e-05	0.00127	CcSEcCtD
Dactinomycin—Asthenia—Docetaxel—melanoma	7.02e-05	0.00124	CcSEcCtD
Dactinomycin—Diarrhoea—Docetaxel—melanoma	6.7e-05	0.00118	CcSEcCtD
Dactinomycin—Vomiting—Docetaxel—melanoma	6.22e-05	0.0011	CcSEcCtD
Dactinomycin—Rash—Docetaxel—melanoma	6.17e-05	0.00109	CcSEcCtD
Dactinomycin—Nausea—Docetaxel—melanoma	5.81e-05	0.00103	CcSEcCtD
Dactinomycin—ABCB1—lymph node—melanoma	5.58e-05	0.00523	CbGeAlD
Dactinomycin—ABCB1—Allograft Rejection—HLA-A—melanoma	2.44e-05	0.00146	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	2.42e-05	0.00145	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—UGT2B10—melanoma	2.38e-05	0.00142	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.35e-05	0.00141	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ACER3—melanoma	2.29e-05	0.00137	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	2.23e-05	0.00133	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—HS3ST5—melanoma	2.21e-05	0.00132	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	2.16e-05	0.00129	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—melanoma	2.13e-05	0.00127	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—UGT2B10—melanoma	2.09e-05	0.00125	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CD80—melanoma	2.06e-05	0.00123	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—ALB—melanoma	2e-05	0.0012	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—HS3ST5—melanoma	1.95e-05	0.00116	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CASP8—melanoma	1.91e-05	0.00114	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TRRAP—melanoma	1.88e-05	0.00113	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CUL3—melanoma	1.88e-05	0.00113	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	1.83e-05	0.0011	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—AKR1B10—melanoma	1.83e-05	0.0011	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.78e-05	0.00106	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	1.76e-05	0.00105	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PLCB4—melanoma	1.68e-05	0.001	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—AKT1—melanoma	1.67e-05	0.001	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	1.66e-05	0.00099	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—FASN—melanoma	1.65e-05	0.000984	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—LUM—melanoma	1.63e-05	0.000976	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IFNG—melanoma	1.63e-05	0.000973	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ABCB1—melanoma	1.62e-05	0.000971	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	1.6e-05	0.000958	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HPSE—melanoma	1.6e-05	0.000957	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIP4K2A—melanoma	1.58e-05	0.000943	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SLC6A11—melanoma	1.58e-05	0.000943	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CUBN—melanoma	1.57e-05	0.000939	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.54e-05	0.00092	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—MTAP—melanoma	1.53e-05	0.000917	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CSPG4—melanoma	1.52e-05	0.000907	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CXCL8—melanoma	1.51e-05	0.000904	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.5e-05	0.000896	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—RPS3—melanoma	1.49e-05	0.000893	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PLCB4—melanoma	1.48e-05	0.000882	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—SKI—melanoma	1.47e-05	0.000879	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CASP3—melanoma	1.45e-05	0.000866	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL2—melanoma	1.45e-05	0.000864	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	1.44e-05	0.000861	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	1.42e-05	0.000848	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIP4K2A—melanoma	1.39e-05	0.00083	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SLC6A11—melanoma	1.39e-05	0.00083	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—LUM—melanoma	1.37e-05	0.000817	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PHGDH—melanoma	1.37e-05	0.000817	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC5A5—melanoma	1.35e-05	0.00081	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	1.35e-05	0.000807	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—MTAP—melanoma	1.35e-05	0.000807	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—HPSE—melanoma	1.34e-05	0.000802	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	1.32e-05	0.00079	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CUBN—melanoma	1.32e-05	0.000787	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	1.31e-05	0.000782	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	1.29e-05	0.000774	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CSPG4—melanoma	1.27e-05	0.00076	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SDHD—melanoma	1.27e-05	0.00076	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—BSG—melanoma	1.27e-05	0.00076	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	1.27e-05	0.000759	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	1.25e-05	0.000745	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ACER3—melanoma	1.24e-05	0.00074	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GPAM—melanoma	1.23e-05	0.000736	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—VEGFA—melanoma	1.23e-05	0.000735	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	1.22e-05	0.000732	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HDAC6—melanoma	1.21e-05	0.000725	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PHGDH—melanoma	1.2e-05	0.000719	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—LUM—melanoma	1.2e-05	0.000719	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	1.2e-05	0.000717	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—HPSE—melanoma	1.18e-05	0.000705	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ABCB1—melanoma	1.17e-05	0.000702	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CUBN—melanoma	1.16e-05	0.000692	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NPPA—melanoma	1.15e-05	0.000688	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	1.14e-05	0.000681	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—UGT2B10—melanoma	1.13e-05	0.000677	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—VCAN—melanoma	1.12e-05	0.000671	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SDHD—melanoma	1.12e-05	0.000669	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—BSG—melanoma	1.12e-05	0.000669	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CSPG4—melanoma	1.12e-05	0.000669	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—WNT5A—melanoma	1.11e-05	0.000666	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GPAM—melanoma	1.08e-05	0.000648	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	1.08e-05	0.000647	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	1.08e-05	0.000644	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—TNF—melanoma	1.05e-05	0.00063	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—HS3ST5—melanoma	1.05e-05	0.000629	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PLA2G6—melanoma	1.05e-05	0.000626	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ABCB1—melanoma	1.03e-05	0.000618	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—ALB—melanoma	1.02e-05	0.000608	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	1.01e-05	0.000606	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	1e-05	0.000599	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	9.44e-06	0.000565	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—VCAN—melanoma	9.4e-06	0.000562	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	9.28e-06	0.000555	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PLA2G6—melanoma	9.21e-06	0.000551	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	9.05e-06	0.000541	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	8.97e-06	0.000536	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—GAB2—melanoma	8.94e-06	0.000535	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.9e-06	0.000532	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FASN—melanoma	8.75e-06	0.000523	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.59e-06	0.000514	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	8.53e-06	0.00051	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HDAC2—melanoma	8.41e-06	0.000503	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FOXO4—melanoma	8.41e-06	0.000503	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CXCR4—melanoma	8.41e-06	0.000503	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CD44—melanoma	8.31e-06	0.000497	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—VCAN—melanoma	8.27e-06	0.000495	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	8.1e-06	0.000484	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	7.98e-06	0.000477	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PLCB4—melanoma	7.98e-06	0.000477	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP17A1—melanoma	7.93e-06	0.000474	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	7.87e-06	0.000471	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.82e-06	0.000468	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—ALB—melanoma	7.72e-06	0.000462	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	7.7e-06	0.00046	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—AKT3—melanoma	7.67e-06	0.000459	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SLC6A11—melanoma	7.5e-06	0.000448	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIP4K2A—melanoma	7.5e-06	0.000448	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GNA11—melanoma	7.49e-06	0.000448	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—ALB—melanoma	7.34e-06	0.000439	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—FASN—melanoma	7.33e-06	0.000438	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	7.32e-06	0.000438	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—MTAP—melanoma	7.29e-06	0.000436	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	7.29e-06	0.000436	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SLC5A5—melanoma	7.21e-06	0.000431	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	7.14e-06	0.000427	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP17A1—melanoma	6.98e-06	0.000417	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GNAQ—melanoma	6.96e-06	0.000416	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CD44—melanoma	6.96e-06	0.000416	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	6.95e-06	0.000416	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	6.89e-06	0.000412	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.82e-06	0.000408	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ERBB4—melanoma	6.78e-06	0.000405	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.75e-06	0.000404	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	6.73e-06	0.000402	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN2B—melanoma	6.72e-06	0.000402	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	6.71e-06	0.000401	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	6.68e-06	0.000399	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP1B1—melanoma	6.67e-06	0.000399	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GNA11—melanoma	6.59e-06	0.000394	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—LUM—melanoma	6.5e-06	0.000389	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PHGDH—melanoma	6.5e-06	0.000389	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CD86—melanoma	6.5e-06	0.000389	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	6.46e-06	0.000386	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—FASN—melanoma	6.45e-06	0.000386	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—HPSE—melanoma	6.38e-06	0.000381	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SLC5A5—melanoma	6.34e-06	0.000379	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FGF1—melanoma	6.3e-06	0.000377	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CUBN—melanoma	6.26e-06	0.000374	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CD44—melanoma	6.13e-06	0.000366	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GNAQ—melanoma	6.13e-06	0.000366	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PDGFRA—melanoma	6.1e-06	0.000365	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	6.06e-06	0.000363	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SDHD—melanoma	6.04e-06	0.000362	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—BSG—melanoma	6.04e-06	0.000362	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CSPG4—melanoma	6.04e-06	0.000362	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PRKCA—melanoma	6.04e-06	0.000361	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ERCC2—melanoma	5.99e-06	0.000358	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MAP2K2—melanoma	5.9e-06	0.000353	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.89e-06	0.000352	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP1B1—melanoma	5.87e-06	0.000351	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GPAM—melanoma	5.85e-06	0.00035	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.73e-06	0.000343	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TERT—melanoma	5.62e-06	0.000336	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HLA-A—melanoma	5.62e-06	0.000336	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—RAC1—melanoma	5.6e-06	0.000335	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	5.58e-06	0.000334	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ABCB1—melanoma	5.5e-06	0.000329	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	5.46e-06	0.000326	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	5.45e-06	0.000326	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HIF1A—melanoma	5.37e-06	0.000321	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	5.2e-06	0.000311	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	5.15e-06	0.000308	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PRKCA—melanoma	5.06e-06	0.000303	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ERCC2—melanoma	5.02e-06	0.0003	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PLA2G6—melanoma	4.98e-06	0.000298	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NOS2—melanoma	4.88e-06	0.000292	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NOTCH1—melanoma	4.84e-06	0.000289	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ABCB1—melanoma	4.84e-06	0.000289	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CD80—melanoma	4.74e-06	0.000283	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.73e-06	0.000283	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—KIT—melanoma	4.73e-06	0.000283	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—APC—melanoma	4.73e-06	0.000283	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—EGF—melanoma	4.68e-06	0.00028	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.58e-06	0.000274	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—VCAN—melanoma	4.47e-06	0.000267	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PRKCA—melanoma	4.45e-06	0.000266	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—BRAF—melanoma	4.45e-06	0.000266	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ERCC2—melanoma	4.41e-06	0.000264	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MAP2K1—melanoma	4.19e-06	0.00025	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CD—melanoma	4.16e-06	0.000249	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.16e-06	0.000249	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FGF2—melanoma	3.98e-06	0.000238	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CG—melanoma	3.96e-06	0.000237	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.87e-06	0.000231	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PPARG—melanoma	3.82e-06	0.000229	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP17A1—melanoma	3.77e-06	0.000226	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MDM2—melanoma	3.73e-06	0.000223	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ERBB2—melanoma	3.67e-06	0.00022	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CB—melanoma	3.63e-06	0.000217	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CD4—melanoma	3.62e-06	0.000216	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTGS2—melanoma	3.59e-06	0.000215	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GNA11—melanoma	3.56e-06	0.000213	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	3.49e-06	0.000209	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—FASN—melanoma	3.49e-06	0.000209	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CG—melanoma	3.49e-06	0.000209	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CD—melanoma	3.48e-06	0.000208	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ALB—melanoma	3.44e-06	0.000206	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SLC5A5—melanoma	3.43e-06	0.000205	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN1B—melanoma	3.4e-06	0.000203	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PPARG—melanoma	3.36e-06	0.000201	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GNAQ—melanoma	3.31e-06	0.000198	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CD44—melanoma	3.31e-06	0.000198	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CTNNB1—melanoma	3.21e-06	0.000192	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP1B1—melanoma	3.18e-06	0.00019	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN1A—melanoma	3.14e-06	0.000188	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTEN—melanoma	3.13e-06	0.000187	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CD—melanoma	3.06e-06	0.000183	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CB—melanoma	3.04e-06	0.000182	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ALB—melanoma	3.03e-06	0.000181	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTGS2—melanoma	3.01e-06	0.00018	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—STAT3—melanoma	2.8e-06	0.000168	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NRAS—melanoma	2.79e-06	0.000167	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MAPK3—melanoma	2.68e-06	0.00016	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CB—melanoma	2.67e-06	0.00016	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTGS2—melanoma	2.65e-06	0.000158	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTEN—melanoma	2.62e-06	0.000157	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MYC—melanoma	2.6e-06	0.000156	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MAPK1—melanoma	2.55e-06	0.000152	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—EGFR—melanoma	2.55e-06	0.000152	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PRKCA—melanoma	2.41e-06	0.000144	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—KRAS—melanoma	2.41e-06	0.000144	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ERCC2—melanoma	2.39e-06	0.000143	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTEN—melanoma	2.31e-06	0.000138	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PIK3CA—melanoma	2.21e-06	0.000132	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HRAS—melanoma	2.04e-06	0.000122	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—IL6—melanoma	1.96e-06	0.000117	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CG—melanoma	1.88e-06	0.000113	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PIK3CA—melanoma	1.85e-06	0.000111	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PPARG—melanoma	1.82e-06	0.000109	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—AKT1—melanoma	1.81e-06	0.000108	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CD—melanoma	1.66e-06	9.91e-05	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ALB—melanoma	1.64e-06	9.78e-05	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PIK3CA—melanoma	1.63e-06	9.74e-05	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—AKT1—melanoma	1.51e-06	9.04e-05	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CB—melanoma	1.44e-06	8.64e-05	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTGS2—melanoma	1.43e-06	8.56e-05	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—AKT1—melanoma	1.33e-06	7.96e-05	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTEN—melanoma	1.25e-06	7.46e-05	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PIK3CA—melanoma	8.8e-07	5.27e-05	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—AKT1—melanoma	7.19e-07	4.3e-05	CbGpPWpGaD
